Published on 22 May 2024 on Simply Wall St. via Yahoo Finance
Insider Stock Buying Reaches US$2.50m On Acasti Pharma
In the last year, multiple insiders have substantially increased their holdings of Acasti Pharma Inc. (NASDAQ:ACST) stock, indicating that insiders' optimism about the company's prospects has increased.
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.